Daley-Yates PT - Search Results

1

The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases.

Daley-Yates PT, Dodwell DJ, Pongchaidecha M, Coleman RE, Howell A. Daley-Yates PT, et al. Calcif Tissue Int. 1991 Dec;49(6):433-5. doi: 10.1007/BF02555856. Calcif Tissue Int. 1991. PMID: 1818770

2

Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia.

Dodwell DJ, Howell A, Morton AR, Daley-Yates PT, Hoggarth CR. Dodwell DJ, et al. Postgrad Med J. 1992 Jun;68(800):434-9. doi: 10.1136/pgmj.68.800.434. Postgrad Med J. 1992. PMID: 1437922 Free PMC article. Clinical Trial.

3

Clearance and tissue uptake following 4-hour and 24-hour infusions of pamidronate in rats.

Pongchaidecha M, Daley-Yates PT. Pongchaidecha M, et al. Drug Metab Dispos. 1993 Jan-Feb;21(1):100-4. Drug Metab Dispos. 1993. PMID: 8095201

4

The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse.

Hoggarth CR, Bennett R, Daley-Yates PT. Hoggarth CR, et al. Calcif Tissue Int. 1991 Dec;49(6):416-20. doi: 10.1007/BF02555853. Calcif Tissue Int. 1991. PMID: 1818767

5

Plasma protein binding of APD: role of calcium and transferrin.

Daley-Yates PT, Cal JC, Cockshott A, Pongchaidecha M, Gilchrist K. Daley-Yates PT, et al. Chem Biol Interact. 1992 Jan;81(1-2):79-89. doi: 10.1016/0009-2797(92)90028-j. Chem Biol Interact. 1992. PMID: 1730149

6

A comparison of the pharmacokinetics of 14C-labelled APD and 99mTc-labelled APD in the mouse.

Daley-Yates PT, Bennett R. Daley-Yates PT, et al. Calcif Tissue Int. 1988 Aug;43(2):125-7. doi: 10.1007/BF02555158. Calcif Tissue Int. 1988. PMID: 3142665

7

Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD), in rats and mice.

Cal JC, Daley-Yates PT. Cal JC, et al. Toxicology. 1990 Dec 17;65(1-2):179-97. doi: 10.1016/0300-483x(90)90088-x. Toxicology. 1990. PMID: 1980383

8

Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography.

Daley-Yates PT, Gifford LA, Hoggarth CR. Daley-Yates PT, et al. J Chromatogr. 1989 May 30;490(2):329-38. doi: 10.1016/s0378-4347(00)82791-7. J Chromatogr. 1989. PMID: 2768406

9

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.

Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A. Brutsche MH, et al. Lancet. 2000 Aug 12;356(9229):556-61. doi: 10.1016/S0140-6736(00)02581-2. Lancet. 2000. PMID: 10950233 Clinical Trial.

10

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.

Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA. Singh SD, et al. Br J Clin Pharmacol. 2003 Apr;55(4):375-81. doi: 10.1046/j.1365-2125.2003.01758.x. Br J Clin Pharmacol. 2003. PMID: 12680886 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters